Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 9
- DOI:
- 10.3760/j.issn:0366-6999.2002.09.001
- Key Word:
- 经皮穿刺间隔心肌消融术;肥厚型梗阻性心肌病;并发症;percutaneous tansluminal septal myocardial ablation;hypertrophic obstructive cardiomyopathy;complication
Abstract： Objective To assess the complications of percutaneous tansluminal septal myocardial ablation (PTSMA) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM).Methods Seventy-two patients with symptomatic left ventricular outflow tract obstruction were diagnosed by echocardiography or catheterization procedures. Absolute ethanol was injected into the target coronary artery branch (branches) for septal myocardial ablation. Documented complications were recorded. Results Sixty-nine patients had severe chest pain, 19 developed different degrees of heart block during the periprocedural period, but only one developed a complete AV block, requiring permanent pace-maker implantation. Temporary right bundle branch block occurred in 50% of patients and permanent block occurred in 38.9% of patients. Acute inferior myocardial infarction occurred in six patients (8.3%) and acute anterior myocardial infarction occurred in one patient. During two-year follow-up of 24 cases, there were no deaths. All patients had improvement in heart function and none experienced heart failure. Conclusion The most common complication of PTSMA is right bundle branch block. The most significant complication of the procedure is heart block. PTSMA is a good technical, non-surgical treatment for HOCM.
- [1]N, Lakkis.New treatment methods for patients with hypertrophic obstructive cardiomyopathy.[J].2000,15.
- [2]Nasser M Lakkis,Sherif F Nagueh,J.Kay Dunn,etc.Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up[J].2000,36(3).
- [3]L, Fananapazir,D, McAreavey.Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.[J].1998,31.
- [4]D G, Blanchard,J, Ross.Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy.[J].1991,14(1).
- [5]Hubert Seggewiss,Ulrich Gleichmann,Lothar Faber,etc.Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and 3-Month Follow-Up in 25 Patients[J].1998,31(2).
- [6]Ommen,SR,Nishimura,RA,Squires,RW,etc.Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertropic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.[J].1999,34(1).
- [7]U, Sigwart.Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.[J].1995,346.
- [8]William Spencer,Nasser Lakkis,Sherif Nagueh,etc.Transcatheter Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy[J].1999,100(11).
- [9]Jae-Joong Kim,Cheol Whan Lee,Seong-Wook Park,etc.Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy[J].1999,83(8).
- [10]S F, Nagueh,N M, Lakkis,K J, Middleton,etc.Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.[J].1999,99.
- [11]F, Airoldi,C, Di Mario,A, Catanoso,etc.Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.[J].2000,1(3).
- [12]Spencer WH 3rd,Lakkis NM,Middleton KJ,etc.Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.[J].2001,103(11).
- [13]W, Ruzy??o,L, Chojnowska,M, Demkow,etc.Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.[J].2000,21.
- [14]Maron BJ.Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy.[J].2000,355(9202).
- [15]Seggewiss H,Faber L,Gleichmann U.Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.[J].1999,47(2).
- [16]P, Spirito,B J, Maron.Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy.[J].1999,33.
- [17]Woltersdorf H,Koerfer R,Kleikamp G,etc.Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological and hemodynamic aspects.[J].2000,41(6).